1. Introduction {#S1}
===============

Every year millions of people suffer the devastating consequences of a traumatic brain injury (TBI) ([@R14]; [@R39]). TBI is a complex disorder that leads to profound deficits in neurological function as a result of progressive pathological events. TBI can be categorized as an open or closed head injury ranging from mild to severe pathology. At the site of impact, moderate to severe brain injuries usually include vascular damage, cell loss, axonal and synaptic damage; however, synaptic dysfunction in the absence of cell loss has also been observed in more distal regions ([@R44]; [@R48]). Moreover, synaptic damage is thought to be a major contributor to chronic neurological symptoms following mild concussive injuries ([@R32]; [@R56]). For this reason, it is important to understand the mechanisms that regulate synaptic stability and plasticity in the traumatic injured brain.

Learning and memory deficits are commonly observed impairments following TBI ([@R51]; [@R72]; [@R81]). Consolidation of short- and long-term memory is attributed to activity-dependent changes in synaptic strength (i.e. synaptic plasticity) in the hippocampus. NMDAR activation is critical for synaptic plasticity, as its activation is known to regulate glutamatergic receptor density in the post-synaptic membrane, bouton size, and synaptic strength ([@R1]; [@R30]; [@R38]). Recently, [d]{.smallcaps}-serine has been shown to function as the endogenous co-agonist for NMDARs, and together with glutamate is essential for synaptic plasticity, learning and memory ([@R7]; [@R29]; [@R59]; [@R82]). [d]{.smallcaps}-serine is synthesized through the racemization of [l]{.smallcaps}-serine by the enzyme serine racemase ([@R83]), though the mechanisms that regulate [d]{.smallcaps}-serine conversion and release after TBI have yet to be explored. What is known is that excessive activation of NMDARs is thought to play a key role in TBI pathology, and underlies excitotoxic cell death ([@R19]; [@R31]). It is less clear whether sub-excitotoxic activation of NMDAR by [d]{.smallcaps}-serine after TBI can lead to synaptic damage.

Receptor tyrosine kinases are also associated with synaptic membranes and play important roles in regulating synaptic formation and function. In particular, Eph receptors (Ephs) have been shown to stabilize post-synaptic densities, regulate excitatory synaptic numbers, glutamate receptor transport, and synaptic plasticity ([@R2]; [@R24]; [@R35]; [@R36]; [@R68]). Both Ephs and their ligands (i.e. ephrins) are membrane bound and can elicit bidirectional signals upon interactions of pre- and post-synaptic membranes ([@R3]; [@R43]; [@R65]). Astrocytes can also interact with neuronal components of the synapse in what is known as the tripartite synapse to regulate synapse formation and plasticity ([@R27]; [@R67]). Astroglial release of glutamate and [d]{.smallcaps}-serine can alter synaptic function, where gliotransmitter levels in the synapse can fine-tune excitatory postsynaptic potentials ([@R4]; [@R26]; [@R27]). Moreover, ephrinB3 interaction with EphB3 and EphA4 in astrocytes is known to influence hippocampal synaptic plasticity through regulation of [d]{.smallcaps}-serine synthesis and release ([@R87]). It is therefore important to understand the role of Eph-mediated signaling events following TBI, specifically the contribution to [d]{.smallcaps}-serine release and synaptic function.

Our findings suggest that elevated levels of [d]{.smallcaps}-serine after TBI may contribute to progressive CNS pathology. We also show that EphB3 negatively regulates excitatory glutamatergic synaptic stability and plasticity after moderate TBI, as observed by decreased [d]{.smallcaps}-serine levels, improved synaptic stability and enhanced long-term potentiation in the absence of EphB3.

2. Materials & methods {#S2}
======================

2.1. Animals {#S3}
------------

EphB3 knockout (EphB3^−/−^) mutant mice were bred on a C57Bl/6 background as previously described ([@R34]; [@R61]). All procedures were performed on both wild type (WT) and EphB3^−/−^ male mice 2--4 months of age and approved by the University of Miami Institutional Animal Care and Use Committee.

2.2. Controlled cortical impact (CCI) injury {#S4}
--------------------------------------------

Mice were initially anesthetized with a ketamine/xylazine cocktail and placed on a heating pad. Mice were placed in a stereotaxic frame, where they remained until the end of the procedure. The head was shaved and the skull was exposed through a skin incision. A 5 mm craniotomy was made over the right parieto-temporal cortex without disturbing the dura, with the epicenter coordinates at bregma: −2.0 mm; lateral: −2.5 mm. Mice were then subjected to a moderate CCI at a velocity of 4 m/s, 0.50 mm depth and 150 ms duration using an eCCI-6.0 device (Custom Design & Fabrication, Richmond, VA). The CCI consists of a pressurized metal piston delivering a blow at the aforementioned parameters directly onto the dura of the brain producing mechanical strain forces similar to those observed in human TBI ([@R62]). Following the impact, the skin was closed using 5-0 Vicryl synthetic absorbent sutures, and animals were placed into a clean cage on a heating pad until recovery from anesthesia. Mice received 0.9% saline and analgesic (Buprenorphine) injections and monitored bi-daily for one week.

2.3. Stereological cell and neuronal counts {#S5}
-------------------------------------------

Mice were anesthetized and perfused with 0.1 M phosphate buffer and 4% paraformaldehyde (PFA). Brains were dissected and serially cryo-sectioned (Leica CM 1900, Leica Biosystems Inc., Buffalo Grove, IL) at 15 µm/section from bregma −1.4 to −2.2 for a total tissue thickness \~1500 µm. For total hippocampal cell counts and regional volumetric analysis, hematoxylin and eosin staining was performed on serial sections. Micro Bright Field StereoInvestigator software package (MBF Bioscience, Williston, VT) was used to contour the dentate gyrus, hilus, CA3 and CA1 areas at 10× magnification. After contouring, a grid of 100 × 100 µm^2^ was placed over each region of interest and hematoxylin-stained nuclei within a random sampling box of 50 × 50 µm^2^ was counted using the optical fractionator at 63 × magnification for unbiased determination of cell number. Investigators were blind to experimental group. For neuronal counts, neuronal labeling with NeuN antibody (Cell Signaling, Beverly, MA) and DAPI was performed on serial sections. Randomized images of each hippocampal region were acquired at 40 × magnification using an Olympus BX50 microscope. ImageJ software was utilized to quantify DAPI-positive and NeuN-positive cells within the dentate granule cell, CA1 and CA3 pyramidal cell layers. Investigators were blind to experimental group.

2.4. Transmission electron microscopy (TEM) {#S6}
-------------------------------------------

Mice were anesthetized and perfused with 2% PFA/2% glutaraldehyde in 0.1 M phosphate buffer. Brains were dissected, embedded in chicken albumin agar and cut into 500 µm sections using a motorized vibrating-blade microtome (Leica VT1000s, Leica Biosystems Inc., Buffalo Grove, IL). CA1 hippocampal regions were dissected, cut into 1 mm^2^ pieces, and further post-fixed with 3% EM grade glutaraldehyde. Ultrathin tissue sections were stained with conventional osmium-uranium-lead method containing 1% ethanolic phosphotungstic acid (EPTA). The CA1 hippocampus was visualized using a Philips CM-10 TEM operating at 80 kV. Sections were placed on a grid and non-overlapping randomized photographs (\>20/section) were taken throughout the entirety of CA1 stratum radiatum. Photographs were digitized, and an investigator blinded to experimental group quantified synapses manually. The inclusion criteria for excitatory synapses included the presence of pre- and post-synaptic membranes with a discernible synaptic cleft, presence of asymmetric pre- and post-synaptic densities, and presence of synaptic vesicles at the presynaptic terminal as described previously ([@R17]; [@R54]). Pre- and post-synaptic densities from quantified synapses were measured for synaptic area and length using ImageJ.

2.5. Western blot analyses {#S7}
--------------------------

Ipsilateral hippocampal tissues from sham and CCI injured mice were homogenized in RIPA buffer with protease and phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and benzonase nuclease (Millipore Corporation, Billerica, MA) and mixed by rocking at 4 °C for at least 15 min. Tissues were centrifuged, supernatant was recovered, samples were diluted and standardized to protein concentrations. Protein samples were separated on 8--10% SDS-PAGE gel and transferred to a nitrocellulose membrane. Membranes were then blocked with 5% milk or 5% BSA in 0.1 M phosphate buffer with 0.1% Tween-20 for 1 h at room temperature (RT) and incubated overnight at 4 °C with primary antibodies. Membranes were incubated for 1 h at RT with HRP-conjugated secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA). Bands were visualized using SuperSignal substrate (ThermoScientific, Pittsburg, PA). The following primary antibodies were used: anti-GluR1, anti-NR1, anti-NR2B (EMD Millipore, Billerica, MA), anti-GFAP (BD Biosciences, San Jose, CA), anti-SNAP25, anti-SNAP23 (ABCAM, Cambridge, MA) and anti-β-tubulin (Sigma-Aldrich, St. Louis, MO) antibodies. ImageJ was used to perform density analysis. Protein measurements were standardized to β-tubulin and normalized to average WT sham signals.

2.6. Intra-hippocampal infusion of ephrinB3 {#S8}
-------------------------------------------

Alzet pumps (1003D, Alzet, Cupertino, CA) were preloaded with 112 µg/kg/day pre-clustered ephrinB3-Fc or Fc-only, while other experiments used 840 µg/kg/day [d]{.smallcaps}-serine or vehicle. Briefly, loaded pumps were connected to a brain infusion catheter and placed in 0.1 M phosphate buffer at 37 °C overnight ([@R79]). After the CCI injury, the infusion device was attached to the stereotactic holder and the tip of the cannula was lowered 1.7 or 2.0 mm into the hippocampus or lateral ventricle, respectively. The infusion device was secured to the skull using Loctite 454 prism gel (Henkel Corp. Rocky Hill, CT). The pump was then placed under the skin in the back of the neck and the incision was closed with suture. Mice were placed in clean heated cages to recover.

2.7. Chemiluminescent assay {#S9}
---------------------------

Mice were anesthetized and the ipsilateral hippocampi were immediately dissected and homogenized in RIPA buffer with protease and phosphatase inhibitor cocktail and benzonase nuclease and incubated by rocking at 4 °C for at least 15 min. Tissues were centrifuged, supernatants were recovered, and samples were diluted and standardized to protein concentrations. [d]{.smallcaps}-serine was measured by a chemiluminescent assay as previously described ([@R83]; [@R87]). A 10 µl sample was mixed with 100 µl of medium containing 100 mM Tris-HCl, pH 8.8, 20 units/ml peroxidase, and 8 µM luminol. To decrease background signal of luminal, 10 µl of [d]{.smallcaps}-amino acid oxidase (DAAO) (75 units/ml) were added after a 15 min delay. Chemiluminescence kinetics was recorded for 4 min at RT with a FLUOstar Omega microplate reader (BMG Labtech, Ortenberg, Germany). The concentration of [d]{.smallcaps}-serine in each sample was compared to a standard curve. The linear range was 50--1000 pmol of [d]{.smallcaps}-serine in the sample and the detection limit was 30 pmol. Glutamate was measured using Amplex Red Glutamic Acid/Glutamate Oxidase Assay kit (Molecular Probes, Eugene, OR) following the manufacturer's protocol. Fluorescence was measured in a FLUOstar Omega microplate reader using excitation in the range of 530--560 nm and emission detection at 590 nm. To correct for background fluorescence, the values were subtracted from control well values (i.e. no glutamic acid).

2.8. Electrophysiology {#S10}
----------------------

### 2.8.1. In vivo electrophysiology {#S11}

Mice were anesthetized with urethane (1.5 g/kg) and placed on a stereotaxic frame. A 25 µm concentric platinum-iridium bipolar stimulation electrode and platinum-iridium recording electrode were inserted through a craniotomy site at bregma: −2.0 mm; lateral: −2.0 mm; depth: 1.4 mm (stimulation electrode) and bregma: −1.8 mm; lateral: −1.4 mm; depth: −1 to −1.5 mm (recording electrode). Concentric platinum-iridium bipolar stimulation electrodes (tip diameter 25 µm, FHC, Bowdoin, ME) were placed in the Schaffer Collaterals and a recording glass micropipette filled with 150 mM sodium chloride (1--3 MΩ) was placed in the CA1 stratum radiatum. Field potentials were recorded and converted to digital using an Axoclamp 2B amplifier, Axon Instruments Digidata 1322A analog-to-digital converter, and Clampex (Axon Instruments) software for data acquisition and analysis. Input-output (I/O) curves were generated by delivering electrical monophasic pulses to the CA3 Schaffer Collaterals from a Grass S88 stimulator and S1U5 stimulus isolation unit, and measuring the field-excitatory post-synaptic potential (fEPSP) at increasing stimulus intensities. Stimulus intensities were then adjusted to give fEPSP amplitude at 45--55% of the maximum. A stable baseline fEPSP slope was recorded at a rate of 1/60 s for at least 30 min. A paired-pulse facilitation protocol was run using inter-pulse intervals of 20 ms, 40 ms, and 80 ms. Long term potentiation (LTP) was induced with high-frequency stimulation (HFS, 2 × 100 Hz, 1 s trains, 20 s inter-train interval). Post-HFS fEPSPs were recorded for at least 60 min. Post-tetanus fEPSP slopes were expressed as a percentage of the average fEPSP slope from the baseline recordings.

### 2.8.2. In vitro electrophysiology {#S12}

Mice were anesthetized using isoflurane and decapitated. Brains rapidly removed, and to reduce tissue damage, were quickly immersed in oxygenated ice-cold fresh high sucrose containing artificial cerebrospinal fluid (high sucrose-aCSF): 100 mM sucrose, 60 mM NaCl, 3 mM KCl, 1.25 mM NaH~2~PO~4~, 28 mM NaHCO~3~, 0.5 mM CaCl~2~, 7 mM MgCl~2~, 0.6 mM ascorbic acid, and 5 mM glucose equilibrated with 95% O~2~:5% CO~2~. Brains received a mid-sagittal hemisection and the ipsilateral hippocampi were carefully dissected from the overlying cortex. The hippocampi were mounted on agarose blocks, and cross-sectioned into 300 µm slices with a motorized vibrating-blade microtome (Leica VT1000s, Leica Biosystems Inc., Buffalo Grove, IL). Slices were gradually transferred from high sucrose-aCSF to a holding chamber containing 50% high sucrose-aCSF/50% aCSF. aCSF contained: 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH~2~PO~4~, 25 mM NaHCO~3~, 2 mM CaCl~2~, 1 mM MgCl~2~, and 25 mM glucose, oxygenated with 95% O~2~:5% CO~2~ at RT. Slices were allowed to recover for at least 1 h in aCSF at RT before transfer to a submersion-type recording chamber perfused with aCSF oxygenated with 95% O~2~:5% CO~2~ at 32 °C. Field potentials were recorded using an Axoclamp 2B amplifier, Axon Instruments Digidata 1400 analog-to-digital converter, and Clampex software for data acquisition and analysis. The recording protocol was the same as used during in vivo electrophysiological recordings.

2.9. Fear conditioning test {#S13}
---------------------------

The fear conditioning apparatus consists of a box (30 × 24 × 21 cm, Coulbourn Instruments, Whitehall, PA) with an electric grid floor (0.8 cm spacing, 4.8 mm diameter rods). Mice were placed in the box for habituation for 600 s. On the second day of the paradigm, mice were placed back in the box for 120 s followed by a 30 s tone (85 dB, 2 kHz) with a 0.7 mA foot shock delivered through the grid floor during the last 2 s of the tone. The animals remained in the box for an additional 60 s after the shock for a total duration of 210 s of training. At 24 h after training, mice were placed in the same box and freezing behavior was measured for 300 s to assess contextual fear conditioning. At 1 h after contextual fear assessment, cue fear conditioning was assessed by placing mice in a chamber with different wall coloration, lighting and scent and measuring freezing behavior for 360 s during which the tone (85 dB, 2 kHz) was delivered for the last 180 s. The box was cleaned with 70% EtOH and an enzymatic cleaner between animals. Freezing behavior was quantified using video-based analysis software (FreezeFrame, Coulbourn Instruments, Whitehall, PA).

2.10. Statistical analyses {#S14}
--------------------------

Data were graphed using GraphPad Prism (GraphPad Inc., SanDiego, CA). Comparisons between WT sham and EphB3^−/−^ sham, WT sham and WT CCI, or EphB3^−/−^ sham and EphB3^−/−^ CCI injured mice were measured. Student's two-tailed *t*-test was used for comparison of two experimental groups. One-way ANOVA or two-way ANOVA was used for comparison of more than two groups, followed by Bonferroni post-hoc correction. Kolmogorov-Smirnov (K-S) test was used to analyze the distribution of synaptic density areas and width in combination with Kruskal-Wallis test in the TEM studies. For hippocampal electrophysiological recordings two-way ANOVA and repeated measures ANOVA with Bonferroni post-hoc correction were used. Data is represented as mean value ± standard error of the mean (SEM).

3. Results {#S15}
==========

3.1. A CCI injury model to examine synaptic dysfunction without hippocampal neuronal loss {#S16}
-----------------------------------------------------------------------------------------

To examine the effects of traumatic brain injury (TBI) on synaptic stability and function, we took advantage of a well-described controlled cortical impact (CCI) injury model ([@R18]; [@R62]; [@R76]; [@R79]). While other TBI models exist, CCI injury allows for accurate replication of biomechanics similar to human TBI ([@R66]; [@R84]; [@R85]), and can be adapted to different injury severities depending on the experimental paradigm ([@R10]; [@R15]; [@R69]; [@R5]). To examine synaptic dysfunction in the TBI environment, we established a moderate mouse controlled cortical impact (CCI) injury model where hippocampal synaptic damage is independent of neuronal loss. Hematoxylin and eosin (H&E) stained CCI injured wild type (WT) tissues showed substantial cortical damage at 7 days post-CCI injury (dpi) as compared with sham controls ([Fig. 1A, B](#F1){ref-type="fig"}); however, no overt hippocampal damage was observed ([Fig. 1B](#F1){ref-type="fig"}) nor at 30 dpi (not shown). High magnification of CA1 pyramidal neurons (CA1) of the hippocampus in Thy-1-YFP reporter mice also showed no visible neuronal damage at 7 dpi ([Fig. 1A', B'](#F1){ref-type="fig"}). Furthermore, significant upregulation in GFAP immunoreactivity was observed in the CA1 hippocampus after CCI injury but not in sham injured mice ([Fig. 1C -- D](#F1){ref-type="fig"}), which is consistent with activating hippocampal injury cascades that lead to hypertrophic astrocytes but no neuronal loss after brain injury ([@R12]; [@R15]; [@R46]).

To determine whether CCI injury affects synaptic function at 7 dpi, we measured CA3-CA1 hippocampal field excitatory post-synaptic potentials (fEPSPs) and long-term potentiation (LTP) in vivo. CCI injury led to a significant deficit in synaptic recruitment at higher stimulus intensities, as observed by a significant difference in the input/output (I/ O) curve at stimulus intensities of 20 and 30 µA between sham and CCI injured mice (p = 0.0313 and p = 0.0162, respectively; [Fig. 1E](#F1){ref-type="fig"}). In addition, examination of LTP showed a significant reduction in the CA3-CA1 fEPSP slope in CCI injured mice (p = 0.0132) when compared with sham controls ([Fig. 1F](#F1){ref-type="fig"}; n = 4--5/group). We next examined hippocampal-dependent learning and memory using a fear-conditioning paradigm known to detect deficits after TBI ([@R80]). No difference was observed in habituation and baseline training; however, WT sham mice displayed significant contextual and cued freezing behavior that was not observed in CCI injured mice (p \< 0.001 and p = 0.0287, respectively; [Fig. 1G](#F1){ref-type="fig"}; n = 7/group). Together, these findings demonstrate that CCI injury results in significant synaptic dysfunction and learning deficits even in the absence of gross hippocampal tissue damage.

To evaluate whether synaptic deficits are independent of hippocampal cell loss or atrophy, we quantified the number of CA1 pyramidal cells, CA3 pyramidal cells and dentate granule cells (DGC) at 7 dpi using non-biased stereology on hematoxylin stained ([Fig. 1H](#F1){ref-type="fig"}; n = 5/ group) and anti-NeuN immunolabeled ([Fig. 1I](#F1){ref-type="fig"}; n = 3/group) hippo-campal tissues in regions directly ventral to the injury epicenter. We also performed tissue volume analysis at 7 dpi between groups using non-biased stereology ([SFig. 1A--D](#SD1){ref-type="supplementary-material"}; n = 5/group). For all analyses, we observed no significant difference in the number or volume of CA1 or CA3 pyramidal cells between sham and CCI injury. We did observe a modest increase in DGC numbers after CCI injury as compared with sham counterparts (p = 0.0324; [Fig. 1H](#F1){ref-type="fig"}), but significant difference was not observed in the NeuN-positive cells ([Fig. 1I](#F1){ref-type="fig"}), DGC or hilus volumes ([SFig. 1C, D](#SD1){ref-type="supplementary-material"}). Quantitative differences between hematoxylin and anti-NeuN counts likely reflect differences in cell identification as previously reported ([@R86]), where hematoxylin counts where based on morphological criteria while anti-NeuN counts were based on nucleated anti-NeuN cell bodies. Together, these findings support a CCI injury model where the mechanisms of synaptic damage can be examined independent of neuronal death.

3.2. EphB3 levels are increased after CCI injury {#S17}
------------------------------------------------

EphB3 signaling is known to have a deleterious effect in tissue recovery ([@R78], [@R79]); however, its effects on synaptic stability and function after CCI injury are still poorly defined. To evaluate the role of EphB3 in the injured hippocampus, we first examined EphB3 levels in the sham and CCI injured hippocampus at 3 and 7 dpi. Western blot analysis showed a significant increase in EphB3 levels at 3 and 7 dpi as compared with sham controls ([Fig. 2A](#F2){ref-type="fig"}; n = 4/group), which correspond to the peak periods of synaptic dysfunction. In the absence of EphB3 (i.e. EphB3^−/−^ mice)we observed reduced gross cortical damage at 7 dpi ([Fig. 2C](#F2){ref-type="fig"}) as compared with WT CCI injury ([Fig. 1B](#F1){ref-type="fig"}) and EphB3^−/−^ sham ([Fig. 2B](#F2){ref-type="fig"}) mice, which supports previous findings ([@R79]). In addition, no overt gross hippocampal damage was observed and stereological quantification of cell numbers showed no differences in CA1 and CA3 pyramidal cell layers ([Fig. 2D](#F2){ref-type="fig"}) or regional hippocampal volumes between sham and CCI injured EphB3^−/−^ mice ([SFig. 1A--D](#SD1){ref-type="supplementary-material"}; n = 5/group). In the injured EphB3^−/−^ hippocampal dentate gyrus ([Fig. 2D](#F2){ref-type="fig"}), we did observe an increase in DGC numbers (p = 0.0324) similar to that observed in WT mice after injury ([Fig. 1H](#F1){ref-type="fig"}).

3.3. CCI injury leads to EphB3-dependent synaptic loss in the hippocampus {#S18}
-------------------------------------------------------------------------

To begin evaluating hippocampal synaptic damage following CCI injury, we used transmission electron microscopy (TEM) to quantify synaptic numbers as well as measured pre- and post-synaptic densities in the ipsilateral CA1 stratum radiatum of WT and EphB3^−/−^ mice at 7 dpi ([Fig. 3](#F3){ref-type="fig"}; n = 4/group). Tissues were cut into ultrathin sections ([Fig. 3A](#F3){ref-type="fig"}), the CA1 was dissected and a placed on a grid ([Fig. 3B](#F3){ref-type="fig"}), and non-overlapping photographs of EPTA-stained CA1 stratum radiatum were taken ([Fig. 3C](#F3){ref-type="fig"}). We then quantified asymmetric (i.e. excitatory) synapses ([@R54]; [@R73]) if they met the following criteria: apposed pre- and post-synaptic densities, the presence of pre-synaptic vesicles and a visually discrete synaptic cleft ([Fig. 3D, E](#F3){ref-type="fig"}). WT CCI injured mice showed a significant \~20% reduction (p \< 0.001) in synaptic numbers compared with sham controls ([Fig. 3F](#F3){ref-type="fig"}). We observed fewer synapses in EphB3^−/−^ sham mice than WT sham mice (p \< 0.001; [Fig. 3F](#F3){ref-type="fig"}), suggesting that EphB3 may regulate synaptic formation or maintenance during development. For this reason, CCI injury values were only compared to sham controls of their respective genotype. Interestingly, we did not observe injury-induced synaptic losses in CCI injured EphB3^−/−^ mice as compared to EphB3^−/−^ sham controls ([Fig. 3F](#F3){ref-type="fig"}).

In addition to overt synaptic loss in WT mice, CCI injury could also lead to disorganization of subsisting synapses, interruption of glutamatergic signaling scaffolds and impaired excitatory signaling ([@R13]; [@R49], [@R50]). Thus, we next quantified the average area of both pre- and post-synaptic density (SD) at 7 dpi in sham and CCI injured WT and EphB3^−/−^ mice. We observed no significant difference in the area of pre-SD and post-SD between WT sham and CCI injured mice ([Fig. 3G, H](#F3){ref-type="fig"}), suggesting that remaining synapses are possibly stabilized within the first week. We did observe a significant increase (p \< 0.001) in the post-SD area in EphB3^−/−^ sham mice compared with WT sham mice ([Fig. 3G](#F3){ref-type="fig"}). However, in the hippocampus of EphB3^−/−^ mice, CCI injury lead to significantly less (p = 0.0023) area covered by the post-SD protein network in the absence of synaptic loss ([Fig. 3G](#F3){ref-type="fig"}), suggesting that EphB3 may play deleterious roles in synaptic maintenance after CCI injury.

To further evaluate synaptic densities, we examined the distribution of synaptic density size between groups ([Fig. 3I, J](#F3){ref-type="fig"}). Post-SD areas showed a left-modal distribution that ranged from 0 to 11,000 nm^2^ for sham-and CCI-injured WT and EphB3^−/−^ synapses ([Fig. 3I](#F3){ref-type="fig"}). The overall distribution of synaptic densities was evaluated using a Kolmogorov-- Smirnov (KS) test, which showed significant variance between the distribution of WT versus EphB3^−/−^ sham (p \< 0.001) and between EphB3^−/−^ sham versus EphB3^−/−^ CCI injured post-SD areas (p \< 0.001). However, no significant differences were observed between groups at any specific area using two-way repeated measures ANOVA. Pre-SD areas also showed a left-modal distribution ranging from 0 to 5400 nm^2^ for sham- and CCI-injured WT and EphB3^−/−^ synapses ([Fig. 3J](#F3){ref-type="fig"}). KS tests did not show significant difference between sham groups or sham versus CCI injury within genotypes. These findings confirm that changes observed in pre- and post-SD areas ([Fig. 3G -- H](#F3){ref-type="fig"}) were due to a shift in the overall sizes of the synaptic densities.

We also evaluated the variability in spine size based on average post-SD diameters, which may differ from increased protein aggregation area ([@R53]). Examination of post-SD diameters showed no difference in average diameter between groups ([Fig. 3K](#F3){ref-type="fig"}); however, analysis of cumulative distributions did show significant difference between groups using KS test. Specifically, we observed a significant difference between EphB3^−/−^ sham versus EphB3^−/−^ CCI injury (p = 0.0053). Two-way repeated measures ANOVA showed significant interactions between diameter and group, where the Bonferroni post-hoc test showed significant difference (p \< 0.01) between EphB3^−/−^ sham and EphB3^−/−^ CCI injury at diameters ranging between 0.21 and 0.25 µm ([SFig. 2A](#SD1){ref-type="supplementary-material"}).

To better evaluate the synaptic unit, we next examined the relationship between post-SD and pre-SD areas (i.e. post-SD:pre-SD ratio), since a synchronous change in spine size is necessary for enhancements in synaptic strength ([@R57]). We observed reversed trends between WT and EphB3^−/−^ ratios after CCI injury, where WT ratios increased significantly (p = 0.0084) while EphB3^−/−^ ratios reduced significantly (p \< 0.001) ([Fig. 3L -- P](#F3){ref-type="fig"}). Examination of cumulative distributions showed group differences between WT sham versus EphB3^−/−^ sham (p = 0.0105), WT sham versus WT CCI injury (p = 0.0024), and EphB3^−/−^ sham versus EphB3^−/−^ CCI injury (p \< 0.001). Two-way repeated measures ANOVA of frequency distributions by ratio size showed no significant interaction between ratio and group ([SFig. 2B](#SD1){ref-type="supplementary-material"}). These findings suggest that reduced synaptic function and behavioral deficits inWT CCI injured mice may be associated with overall synaptic loss as well as dysregulation of the synaptic unit within the remaining synapses.

3.4. Absence of EphB3 signaling improves synaptic plasticity after CCI injury {#S19}
-----------------------------------------------------------------------------

To determine whether synaptic function is affected by the EphB3-dependent ultrastructural changes after CCI injury, we examined CA3-CA1 hippocampal field excitatory postsynaptic potentials (fEPSPs) in vivo in the presence and absence of EphB3 ([Fig. 4](#F4){ref-type="fig"}; n = 4--6/group). To assess basal synaptic transmission we recorded input-output (I/O) curves at increasing stimulus intensities, and observed no significant interaction among animal groups and stimulus intensities ([Fig. 4A](#F4){ref-type="fig"}); however, we did observe significant differences in fEPSP slope at different stimulus intensities (p \< 0.0001) and between animal groups (p = 0.0132). As we observed in our initial characterization of our CCI injury model, WT mice subjected to CCI injury exhibit a significant downward shift in the I/O curve at higher stimulus intensities. Conversely, when we measured the I/O curves in EphB3^−/−^ mice, we observed no significant difference in synaptic recruitment after CCI injury compared to sham ([Fig. 4A](#F4){ref-type="fig"}). Examination of paired pulse facilitation (PPF), a measure of presynaptic function, revealed no significant differences between animal groups ([Fig. 4B](#F4){ref-type="fig"}). These findings are consistent with our in vitro hippocampal slice recordings ([SFig. 3A](#SD1){ref-type="supplementary-material"}) and corroborate our ultrastructural data that the effects observed after CCI injury are mainly post-synaptic in nature. Finally, examination of long-term potentiation (LTP) in vivo at the CA1 hippocampal synapse showed a significant interaction between animal group and time (p \< 0.0001) and main effect for animal groups (p = 0.0131) and time (p \< 0.0001) ([Fig. 4C](#F4){ref-type="fig"}). Analysis of fEPSP slope post-HFS (high frequency stimulation) revealed significant reductions in both early and late LTP in WT CCI injured mice (p = 0.0075 and p = 0.0064, respectively) that were not observed in EphB3^−/−^ CCI injured mice when compared to genotype-matched shams ([Fig. 4C -- E](#F4){ref-type="fig"}). Similarly, recordings from hippocampal slices harvested at 7 dpi from CCI injured WT mice showed reductions in fEPSP slope, but not in slices from CCI injured EphB3^−/−^ mice ([SFig. 3B -- D](#SD1){ref-type="supplementary-material"}). These findings support a deleterious role of EphB3 in synaptic function after CCI injury.

3.5. Absence of EphB3 signaling results in improved hippocampal learning after CCI injury {#S20}
-----------------------------------------------------------------------------------------

We next examined hippocampal-dependent learning and memory using a fear-conditioning paradigm. Following injury, WT and EphB3^−/−^ mice were habituated at 5 dpi, trained at 6 dpi and tested for freezing behavior at 7 dpi. No significant differences were observed between sham and CCI or between genotypes during training periods ([Fig. 5](#F5){ref-type="fig"}; n = 8--15/group). During the contextual testing period, we observed a main effect for animal groups (p \< 0.0001). CCI injury led to a significant (p \< 0.0001)\~50% reduction in contextual and cued freezing behavior in WT CCI injured mice when compared with WT sham mice. Contrarily, EphB3^−/−^ CCI injured mice performed statistically similar to sham controls in both contextual and cued learning paradigms, although a trend towards reduced performance after injury was observed, possibly due to extra-hippocampal damage following CCI injury. These findings support our electrophysiological recordings that suggest activation of EphB3 may exacerbate injury-induced deficits in hippocampal function.

3.6. EphB3 does not affect injury-induced changes in hippocampal synaptic proteins {#S21}
----------------------------------------------------------------------------------

To investigate the molecular basis of the changes in synaptic plasticity observed in CCI-injured hippocampal neurons in the presence and absence of EphB3, we examined the expression of key synaptic proteins essential for excitatory synaptic transmission. Specifically, we quantified protein levels for post-synaptic glutamatergic receptor subunits (i.e. GluR1, NR1 and NR2B) and synaptosomal-associated protein-23 (SNAP23) and −25 (SNAP25) in sham and CCI injured whole hippocampal tissues at 7 dpi using Western blot analysis ([Fig. 6](#F6){ref-type="fig"}; n = 4/group). We observed stable levels of the AMPAR subunit GluR1 regardless of genotype or injury state ([Fig. 6A](#F6){ref-type="fig"}). The NMDAR subunits NR1 and NR2B contribute to hippocampal learning and memory as well as injury-induced excitotoxicity ([@R21]; [@R64]). NR1 subunits, the site for [d]{.smallcaps}-serine binding, showed no significant differences from sham controls for either genotype ([Fig. 6B](#F6){ref-type="fig"}). In WT mice we observed a significant increase in NR2B levels after CCI injury (p = 0.0293) that was also observed in EphB3^−/−^ mice as compared with their respective sham controls (p = 0.0159) ([Fig. 6C](#F6){ref-type="fig"}). We also examined SNARE complex proteins, SNAP-25 and SNAP-23, involved in neuronal and astrocytic vesicular release, respectively. We did not observe significant differences in SNAP-25 nor SNAP-23 levels after CCI injury for either WT or EphB3^−/−^ mice ([Fig. 6D, E](#F6){ref-type="fig"}). Finally, since increased glial fibrillary acidic protein (GFAP) levels are a hallmark of reactive astroctyes after brain injury, we examined whether WT and EphB3^−/−^ mice showed differences in GFAP expression at 7 dpi. Similar increases in GFAP immunoreactivity were observed between WT (p = 0.0003) and EphB3^−/−^ (p = 0.0002) mice ([Fig. 6F](#F6){ref-type="fig"}). Together, these findings suggest that significant variances in core synaptic proteins do not underlie the functional differences observed between WT and EphB3^−/−^ mice after CCI injury.

3.7. EphB3 regulates [d]{.smallcaps}-serine but not glutamate levels after CCI injury {#S22}
-------------------------------------------------------------------------------------

We had previously shown that EphB3 can regulate [d]{.smallcaps}-serine levels in the naïve brain ([@R87]), while others have shown [d]{.smallcaps}-serine can exacerbate excitotoxic effects of NMDA hyper-activation after injury ([@R42]; [@R74]). Therefore, we analyzed transmitter levels in sham and CCI injured whole hippocampi in the presence and absence of EphB3 using a chemiluminescent assay ([Fig. 7](#F7){ref-type="fig"}; n = 6--7/group). In the WT hippocampus during the acute CCI injury period, the [d]{.smallcaps}-serine levels increased at 4 and 24 h post-CCI injury (hpi) as compared with sham controls (p = 0.0032 and p = 0.034, respectively; [Fig. 7A](#F7){ref-type="fig"}), but returned to baseline by 3 dpi and were maintained for at least 7 dpi (not shown). Examination of glutamate levels at the same time points showed no significant difference in WT CCI injured tissues compared to WT sham controls ([Fig. 7B](#F7){ref-type="fig"}), and these basal levels were also maintained for at least 7 dpi (not shown). When we compared the level of [d]{.smallcaps}-serine in EphB3^−/−^ shams, we observed no significant difference from WT shams. Strikingly, in the CCI injured EphB3^−/−^ hippocampus, [d]{.smallcaps}-serine levels were not increased at 4 and 24 hpi ([Fig. 7A](#F7){ref-type="fig"}).

Next, we examined whether ephrinB3 stimulation of Eph signaling would augment [d]{.smallcaps}-serine or glutamate levels in WT mice at 3 dpi, a time when transmitter levels have returned to baseline. Infusion of clustered ephrinB3-Fc (112 µg/kg/day) for 3 days into the ipsilateral hippocampus resulted in a significant increase in [d]{.smallcaps}-serine levels in hippocampi from WT mice but not EphB3^−/−^/EphA4^−/−^ double knockout mice ([Fig. 7C](#F7){ref-type="fig"}). EphB3^−/−^/EphA4^−/−^ mice where used to eliminate potential off target interactions with ephrinB3. Control anti-human-Fc molecules showed no effect on [d]{.smallcaps}-serine levels as compared to non-infused naïve or sham mice. Furthermore, application of clustered ephrinB3-Fc did not alter glutamate levels in either WT or EphB3^−/−^/ EphA4^−/−^ mice ([Fig. 7D](#F7){ref-type="fig"}).

3.8. Increased [d]{.smallcaps}-serine can reverse the enhanced synaptic plasticity observed in EphB3^−/−^ mice after CCI injury {#S23}
-------------------------------------------------------------------------------------------------------------------------------

To validate our conclusion that CCI injury-induced synaptic dysfunction is aggravated by EphB3 regulation of [d]{.smallcaps}-serine levels, we examined CA3-CA1 hippocampal fEPSPs in vivo in CCI injured EphB3^−/−^ mice after vehicle or [d]{.smallcaps}-serine (840 µg/kg/day) infusion ([Fig. 8](#F8){ref-type="fig"}; n = 6/ group). We infused [d]{.smallcaps}-serine or vehicle into the contralateral ventricle for 3 days after CCI injury. EphB3^−/−^ mice that received [d]{.smallcaps}-serine infusion demonstrated reduced basal synaptic transmission revealed by a downward shifted I/O curve at stimulation intensities of 20 µA or higher compared with vehicle-infused controls ([Fig. 8A](#F8){ref-type="fig"}). Two-way repeated measures ANOVA showed significant interaction between groups and stimulus intensity (p \< 0.0001), where the Bonferroni post-hoc test showed significant difference between CCI injured EphB3^−/−^ vehicle-and [d]{.smallcaps}-serine-treated mice (p \< 0.001). No significant differences were observed in PPF between groups ([Fig. 8B](#F8){ref-type="fig"}); however, significant differences were observed in LTP. Specifically, we observed a significant interaction between groups and time(p \< 0.0001) and main effect for animal groups (EphB3^−/−^ CCI-injured vehicle- vs. [d]{.smallcaps}-serine-infused; p = 0.0087) and time (p \< 0.0001) ([Fig. 8C](#F8){ref-type="fig"}). Analysis of fEPSP slope post-HFS revealed that [d]{.smallcaps}-serine infusion resulted in significant reductions in both early and late LTP in EphB3^−/−^ CCI injured mice when compared with vehicle-infused mice (p \< 0.0001; [Fig. 8C -- E](#F8){ref-type="fig"}). These findings support our observations that increased [d]{.smallcaps}-serine levels in the hippocampus are detrimental to synaptic function, and that EphB3 signaling may regulate synaptic dysfunction after CCI injury through enhanced [d]{.smallcaps}-serine synthesis and release.

4. Discussion {#S24}
=============

Synaptic dysfunction and impaired plasticity can have a significant impact on motor, sensory and cognitive functions in TBI patients. Neuronal cell death is a predominant underlying cause for synaptic loss in regions of tissue damage; however, synaptic dysfunction is also present in more distal brain regions where neuronal loss is not observed ([@R51]). To begin to examine synaptic dysfunction within the complex and evolving TBI environment, we have developed a moderate CCI injury model that leads to hippocampal synaptic damage without neuronal losses. We then examined the role of ephrins and Eph receptors in synaptic stability and function after TBI. In the CCI injured hippocampus, we found that EphB3^−/−^ mice showed stable numbers of synapses compared to sham controls, and improved synaptic plasticity and learning behavior as compared with WT CCI injured mice. Comparison of key synaptic proteins essential for excitatory synaptic transmission showed no differences between WT and EphB3^−/−^ mice; however, increases in the NMDAR co-agonist [d]{.smallcaps}-serine following CCI injury were significantly reduced in the absence of EphB3. Furthermore, rescuing [d]{.smallcaps}-serine levels in EphB3^−/−^ mice could recapitulate the synaptic deficits observed in WT CCI injured mice. These findings suggest that elevated [d]{.smallcaps}-serine levels in the hippocampus may play deleterious roles by destabilizing synapses after TBI, and are in part regulated by ephrin-EphB3 signaling.

Our observation that CCI injury results in approximately 20% synaptic losses, and \>50% reduction in LTP and learning in the first week suggests that synaptic loss and dysfunction together may underlie the observed functional deficits. Our observed losses in excitatory synapses in the mouse hippocampus are less pronounced than the \~50% reduction in CA1 synapses in rats after CCI injury ([@R70]). This discrepancy could be attributed to species-specific effects but also a higher injury severity, which also lead to CA3 pyramidal cell death. Alternatively, changes in synaptic size and morphology may also contribute to functional deficits ([@R13]; [@R22]; [@R52]). After injury the main difference observed was an increase in the ratio between post-SD to pre-SD area in WT mice. This could be due to spine enlargement, a reduction of presynaptic bouton size, or a combination of both. However, the opposite effect was observed in the synaptic unit of EphB3^−/−^ mice after injury. When taken together with the deficits in hippocampal function observed, these findings suggest that synchronous changes in both elements of synapse morphology are important for structural stabilization and plasticity ([@R57]). Furthermore, excess activation by increased levels of [d]{.smallcaps}-serine could be participating in destabilizing the synapse and causing synaptic damage ([@R74]).

Alterations in the levels of different synaptic proteins have also been associated with deficits in synaptic plasticity after TBI ([@R63]; [@R77]; [@R80]). The co-agonist binding site for [d]{.smallcaps}-serine is located on NR1 subunits ([@R41]; [@R59]). Interestingly, NR1 protein levels did not change after CCI injury for either group, suggesting that increase in [d]{.smallcaps}-serine after injury leads to increase binding probability ([@R20]) and could enhance NMDA-dependent glutamatergic signaling. In the CCI injured hippocampus, we observed increased levels of the NR2B subunit of the NMDAR in bothWT and EphB3^−/−^ mice, which has been shown to be associated with extra-synaptic NMDARs and the detrimental effects of NMDAR over-activation ([@R6]; [@R30]; [@R31]). Regulation of NMDARs after injury seems to be temporally dependent and differs between injury models ([@R23]; [@R37]; [@R45]; [@R63]; [@R71]; [@R75]). In more severe models, an acute transient reduction in NR2B levels is followed by protein up-regulation at later periods ([@R11]; [@R45]), while no difference is observed in less severe models ([@R23]; [@R63]). Despite these discrepancies, a shift in the relative amounts of synaptic NR2A to extra-synaptic NR2B receptors has been well established to mediate damage caused by initial injury ([@R23]; [@R63]; [@R75]), and likely contributes to the CCI injury-induced deficits observed in WT mice. However, increased NR2B receptors in EphB3^−/−^ mice did not result in synaptic damage or loss, suggesting that reductions in the NMDAR co-agonist [d]{.smallcaps}-serine likely underlie the reduced synaptic damage observed in these mice. EphB receptors have been shown to play roles in glutamate receptor activation, trafficking and localization ([@R2]; [@R24]; [@R33]; [@R40]). We cannot rule out that in EphB3 deficient mice NR2B receptors may remain in the cytoplasm, are unable to become incorporated into the extra-synaptic membranes and do not contribute to detrimental effects of over-activation.

Since our model of CCI injury did not involve hippocampal neuron loss, it suggests that neuronal excitotoxicity may be below the apoptotic threshold in the hippocampus. It is well accepted that glutamate excitotoxicity results from an acute release of glutamate from neurons within the first minutes after trauma, and leads to excessive calcium influx through over-activation of NMDARs, initiation of pro-apoptotic signaling cascades, and ultimately neuronal damage ([@R19]; [@R60]). While this likely occurs in the cortex in our model, we did not observe neuronal loss in the hippocampus even at regions directly ventral to the injury epicenter. Furthermore, there was no significant difference in total hippocampal glutamate levels at 4 h post-injury (hpi), a time-point where glutamate levels have returned to baseline ([@R60]) and the earliest time-point we tested. Conversely, the NMDAR co-agonist [d]{.smallcaps}-serine is up-regulated hours to days after CCI injury and contributes to synaptic damage but not cell death. Enhanced [d]{.smallcaps}-serine levels have also been observed in other peripheral and CNS injury models ([@R47]; [@R58]). Moreover, pharmacological reductions in [d]{.smallcaps}-serine levels have been shown to protect neurons from excitotoxic insult ([@R28]; [@R74]). In the absence of EphB3, increased [d]{.smallcaps}-serine levels were not observed after CCI injury. This provides support to our previous gain-of-function studies showing that ephrinB3 stimulation of EphB3 could increase [d]{.smallcaps}-serine levels in hippocampal slices and cultured astrocytes ([@R87]). Excessive [d]{.smallcaps}-serine levels can induce synaptic damage and reverse the rescue effects associated with the absence of EphB3 after CCI injury; however, the addition of [d]{.smallcaps}-serine by itself was not sufficient to induce NMDA-mediated synaptic damage in hippocampal slices ([@R42]). Together, these findings support a role for EphB3 signaling in regulating [d]{.smallcaps}-serine levels as a novel mechanism by which EphB3 receptors can potentiate damage in the traumatic injured brain. Additional studies are needed to determine how these effects are mediated by EphB3 signaling and establish if [d]{.smallcaps}-serine release is from neurons and/or astrocytes.

TBI patients typically live with life-long cognitive impairment even in the absence of significant tissue pathology ([@R8]; [@R25]; [@R55]). To date, most neuroprotective strategies have focused on preserving cell survival, preventing glutamate excitotoxicity, and inhibiting secondary inflammatory responses ([@R9]; [@R16]). Our findings suggest that synaptic loss and dysfunction may be an important therapeutic target. Understanding the mechanisms regulating [d]{.smallcaps}-serine and NMDARs contributing to the balance of synaptic stability versus dysfunction will have important neuroprotective consequences. Our study suggests Eph receptor signaling plays a role in regulating this balance, whereby inhibiting Eph receptor signaling could lead to improved synaptic numbers and function after TBI.
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![CCI injury model of synaptic dysfunction without hippocampal neuronal losses. Hematoxylin and eosin stained tissues showing gross morphological damage 7 dpi after sham (A) and CCI (B) injury. Rectangles indicate region for images in A'--B' and C--D. High magnification confocal images of CA1 pyramidal neurons in Thy-1-YFP mice show neuronal dendritic densities in sham (A') and CCI injured (B') mice. Increased astrocyte (GFAP) reactivity and hypertrophy, a hallmark of brain injury, is observed in the CA1 region of the after CCI injury (D) as compared with sham (C) mice. (E) Significant downward shift in I/O curve of fEPSPs recorded from CA1 stratum radiatum in vivo at increasing intensities of stimulation in CCI injured mice as compared with sham mice. Insets show sample fEPSP traces for I/O curve. (F) Tetanic high frequency stimulation (HFS) shows enhanced LTP in vivo in sham but not CCI injured mice, where fEPSP slopes were normalized to baseline. Inset depicts representative pre- and post-HFS traces per group. E and F, sham n = 5 and CCI injury n = 4. (G) Significant decrease in percent freezing behavior in CCI mice compared with sham mice in both contextual and cued testing (mean ± SEM; n = 7/group). Quantitative cell counts from hematoxylin stained (H) and anti-NeuN immunoreactive (I) CA1, CA3, and DGC by non-biased stereology (n = 5/group). All data presented as mean ± SEM. \*p \< 0.05 and \*\*\*p \< 0.001 compared with sham controls, \^\^\^p \< 0.001 compared with habituation. Ctx, cortex; Hipp, hippocampus; CA1, CA1 pyramidal cells; CA3, CA3 pyramidal cells; DGC, dentate granule cells.](nihms872529f1){#F1}

![Increased levels of EphB3 does not affect cell survival in the hippocampus after CCI injury. (A) Western blots show increased hippocampal EphB3 protein levels at 3 and 7 dpi in WT mice, which were standardized to β-tubulin and normalized to sham (mean ± SEM; n = 4/group, repeated in triplicate). For full blots see [SFig. 4](#SD1){ref-type="supplementary-material"}. Hematoxylin and eosin stained EphB3^−/−^ sham (B) and CCI (C) injured tissue showing gross morphological damage. (D) Number of hippocampal cells within each region in EphB3^−/−^ sham and CCI injured mice (mean ± SEM; n = 5/group). \*p \< 0.05 and \*\*p \< 0.01.](nihms872529f2){#F2}

![CCI injury leads to EphB3-dependent synaptic loss and alterations in pre- and post-synaptic densities in the hippocampus. (A) Cresyl violet stain of hippocampal tissue, where box indicates region within CA1 stratum radiatum selected for sectioning and grid placement. (B) Grid numbers represent random sampling fields for image acquisition (scale bar = 500 µM). (C) Representative 25,000× electron micrograph of CA1 stratum radiatum with EPTA-stained excitatory synapses (scale bar = 50 µM). High magnification images of synapses with asymmetrical pre- and post-SDs (D) and clear, delineated synaptic cleft and pre-synaptic vesicles (E). (F) CCI injury resulted in a reduction in synaptic numbers in WT, but not EphB3^−/−^ when compared with sham controls. (G) Quantification of mean post-SD area showed EphB3^−/−^ shams had increased post-SD area when compared with both WT sham and EphB3^−/−^ CCI group. (H) Quantification of mean pre-SD area showed no difference between groups. Frequency distribution plots show positively-skewed curve of post-SD area (I) and pre-SD area (J). (K) Quantification of mean post-SD diameter showed no significant differences between groups. (L) Comparison of the ratio between post-SD to pre-SD areas showed opposing CCI injury-induced effects in WT and EphB3^−/−^ mice, where CCI lead to an increase in WT ratio and decrease in EphB3^−/−^ ratio. (M--P) Representative synapses for each group reflect changes observed in synaptic quantifications. All data presented as mean ± SEM with n = 4/group with at least 20 micrographs per animal. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 compared with WT sham, and ^\#\#^p \< 0.01; ^\#\#\#^p \< 0.001 compared with EphB3^−/−^ sham.](nihms872529f3){#F3}

![Synaptic plasticity is significantly reduced in the hippocampus at 7 dpi in WT but not EphB3^−/−^ mice. (A) I/O curve plotting the in vivo hippocampal fEPSP at increasing stimulus intensities shows CCI injury in WT mice resulted in a significant downward shift at higher stimulus intensities, while no significant difference was observed in the EphB3^−/−^ CCI group when compared to EphB3^−/−^ sham group. Inset, superimposed representative traces of evoked fEPSPs at increasing current intensities. (B) Examination of PPF, the ratio of second fEPSP to the first fEPSP slope, revealed no significant differences between animal groups. (C) Examination of LTP, normalized to baseline fEPSP slope, in vivo at the CA1 hippocampal synapse showed significant CCI injury-induced deficit in WT but not EphB3^−/−^ mice. Analysis of fEPSP slope post-HFS revealed that injury resulted in significant reductions in both early (D) and late (E) phase LTP in WT CCI mice when compared with WT sham mice. No differences were observed between EphB3^−/−^ sham and EphB3^−/−^ CCI-injured mice for either early or late LTP responses. All data presented as mean ± SEM. WT sham, n = 5; WT CCI, n = 4; EphB3^−/−^ sham, n = 6; EphB3^−/−^ CCI, n = 5. \*p \< 0.05, \*\*p \< 0.01 compared with WT sham.](nihms872529f4){#F4}

![Hippocampal learning is significantly reduced at 7 dpi in WT but not EphB3^−/−^ mice. Hippocampal-dependent fear-conditioning behavior quantified as percent freezing showed no significant differences between sham and CCI and between genotypes at baseline; however, a significant decrease in freezing behavior in both contextual and cued learning was observed in WT CCI mice when compared with WT sham mice. Nonsignificant reductions were observed in EphB3^−/−^ CCI injured mice compared to EphB3^−/−^ sham mice in both contextual and cued learning. Data presented as mean ± SEM. WT sham, n = 10; WT CCI, n = 15; EphB3^−/−^ sham, n = 10; EphB3^−/−^ CCI, n = 8. \*\*\*p \< 0.001 compared with WT sham.](nihms872529f5){#F5}

![CCI-induced alterations in synaptic protein levels are similar in WT and EphB3^−/−^ hippocampi at 7 dpi. CCI injury did not result in significant changes in levels of GluR1 (A), NR1 (B), SNAP-25 (D) and SNAP-23 (E), but NR2B (C) was upregulated in both WT and EphB3^−/−^ mice. (F) GFAP, a marker of reactive astrocytosis, was significantly upregulated after CCI with no differences between WT and EphB3^−/−^ CCI groups. Insets, representative Western blots for each protein, including beta-tubulin as a loading control. For full blots see [SFig. 4](#SD1){ref-type="supplementary-material"}. All data presented as mean ± SEM; n = 4/group, repeated in triplicate. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 compared with sham control.](nihms872529f6){#F6}

![Eph receptor signaling regulates injury-induced changes in [d]{.smallcaps}-serine but not glutamate levels in the hippocampus. CCI injury lead to significant increases in total levels of [d]{.smallcaps}-serine in WT but not EphB3^−/−^ hippocampi at 4 and 24 hpi (A), while no significant changes were observed in total glutamate levels (B) at these time points. EphrinB3 stimulation of Eph signaling lead to increased levels of [d]{.smallcaps}-serine in WT but not EphB3^−/−^/EphA4^−/−^ mice at 3 dpi (C), while having no effect on levels of glutamate in both groups of mice (D). All data presented as mean ± SEM; A, n = 7/group; B, n = 6/group; C, n = 7/group; D, n = 6/group. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 compared with WT sham.](nihms872529f7){#F7}

![Infusion of [d]{.smallcaps}-serine can reverse the enhanced synaptic plasticity observed in EphB3^−/−^ mice at 7 dpi. (A) Basal synaptic transmission is diminished after [d]{.smallcaps}-serine but not vehicle infusion in EphB3^−/−^ mice, as seen by downward shift in I/O curve in current intensities of 20 mA or higher. Inset, superimposed representative traces of evoked fEPSPs at increasing current intensities. (B) Examination of presynaptic function through PPF revealed no significant differences between animal groups. (C--E) A significant reduction in LTP was observed in [d]{.smallcaps}-serine- versus vehicle-treated EphB3^−/−^ mice. Examination of LTP in vivo at the CA1 hippocampal synapse showed a significant injury-induced deficit in [d]{.smallcaps}-serine but not vehicle-infused EphB3^−/−^ mice (C). Analysis of fEPSP slope post-HFS revealed that injury resulted in significant reductions in both early (D) and late (E) phase LTP in [d]{.smallcaps}-serine infused EphB3^−/−^ mice when compared with vehicle-infused EphB3^−/−^ mice. All data presented as mean ± SEM; EphB3^−/−^ CCI + vehicle, n = 6; EphB3^−/−^ CCI + [d]{.smallcaps}-serine, n = 6. \*\*p \< 0.01, \*\*\*p \< 0.001 compared with vehicle-infused group.](nihms872529f8){#F8}
